NCT06492135View on ClinicalTrials.gov

A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 12, 2024

Primary Completion Date

April 15, 2025

Study Completion Date

April 15, 2025

Conditions
OverweightObesity
Interventions
DRUG

survodutide

survodutide

Trial Locations (1)

200031

Shanghai Central Hospital of Xuhui District, Shanghai

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06492135 - A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the Body | Biotech Hunter | Biotech Hunter